Document is current

Article History

First Online: 23 July 2020

Compliance with Ethical Standards

:

: Rhonda L. Bitting and Michael Goodman declare no conflict of interest. Daniel J. George has received research funding from Acerta Pharmaceuticals, Astellas, Bayer H/C Pharmaceuticals, Bristol-Myers Squibb, Calithera, Capio Biosciences, Exelixis, Janssen Pharmaceuticals, Novartis, Pfizer, and Sanofi; has receive compensation from Astellas, AstraZeneca, Bayer H/C Pharmaceuticals, Bristol-Myers Squibb, EMD Serona, Exelixis, Flatiron Health, Janssen Pharmaceuticals, Merck, Sharp & Dohme, Michael J. Hennessey Assoc, Myovant Sciences, Inc., Novartis, Physicians’ Education Resource, Sanofi, Vizuri Health Sciences, and PlatformQ for service as a consultant; has served as an independent contractor for Axess Oncology; has received speaker’s honoraria from Bayer H/C Pharmaceuticals, Exelixis, and Sanofi; has received compensation for service on advisory boards from AstraZeneca and Modra Pharmaceuticals B.V.; has received honoraria from Ipsen, UroGPO, and UroToday; has received compensation for serving on steering committees for NCI Genitourinary, Nektar Therapeutics, and Pfizer; has received reimbursement for travel expenses from Bayer H/C Pharmaceuticals, Exelixis, Sanofi, and UroToday; and is a Senior Editor for the American Association for Cancer Research.

: This article does not contain any studies with human or animal subjects performed by any of the authors.